Breakthrough Gene-Editing Method Destroys HIV DNA in Infected Cells: A Powerful Hope for Millions
A groundbreaking study from the University of Nebraska Medical Center has unveiled a promising approach for potentially curing HIV, offering hope to the four crore people living with the virus worldwide. Traditional treatments only suppress HIV, but this cutting-edge CRISPR-based gene-editing technique demonstrates the potential to excise the virus from infected cells entirely.
In 2024, statistics revealed that 87 percent of individuals with HIV were aware of their status, 77 percent received treatment, and 73 percent managed to suppress their viral loads. Despite this progress, the need for a definitive cure remains pressing, particularly given HIV’s ability to integrate into the DNA of immune cells and lie dormant, evading antiretroviral drugs.
The research highlights the challenge posed by HIV’s numerous strains-over 79,000 documented variants complicate treatment options. Historically, gene-editing tools like CRISPR-Cas9 faced limitations due to this vast diversity. However, the Nebraska team has crafted a novel version of the tool that targets stable genetic regions common across multiple HIV strains, achieving up to 100 percent viral excision in laboratory experiments. Their work, published in Lancet eBioMedicine, provides a crucial proof of concept, indicating that the genetic material of HIV can be accurately removed from infected cells.
Central to their success was the design of guide RNAs derived from 4,004 HIV-1 strains, focusing on the stable tat gene responsible for viral replication. Their system, referred to as TatDE, demonstrated an average reduction of 82 percent in viral replication across seven strains. When administered via lipid nanoparticles-similar to those used in COVID-19 vaccines-the TatDE system achieved nearly complete viral removal in certain models. Importantly, researchers reported no off-target effects in human DNA, a significant milestone in gene therapy.
Despite the promising results, challenges remain. A study from the University of Pisa warns that excised viral DNA does not simply dissipate but can form circular molecules within the cell, which may reassemble and reactivate. This suggests that a single cut may not be sufficient to eradicate the threat effectively. “This work stresses the importance of implementing CRISPR-Cas9 strategies in vivo to achieve cleavage of the HIV-1 genome at multiple sites,” the authors emphasized.
Another challenge lies in delivering the CRISPR components to the right cells. The Nebraska team’s lipid nanoparticles successfully navigated to macrophages-critical immune cells that harbor HIV-confirming their capacity to combat the virus. Concurrently, researchers at Melbourne’s Doherty Institute have developed an innovative lipid nanoparticle, LNP X, designed to penetrate previously resistant white blood cells, offering additional avenues for treatment.
While progress is notable, key questions linger regarding the efficacy of these approaches. Dr. Jonathan Stoye, a retrovirologist at the Francis Crick Institute, highlights a significant uncertainty: “Do you need to eliminate the entire reservoir for success, or just the major part?” Exploring whether even a small percentage of surviving latent virus could reignite infection is vital for future strategies.
The Nebraska researchers recognize the need for extensive validation against various HIV strains, including whole-genome sequencing to ensure precision of targeted edits. Their ambition remains clear: every infected cell must be excised to achieve a true cure. As they work toward this goal, the horizon for HIV treatment-and the hope it brings-continues to expand.
Original Source: https://thesouthfirst.com/health/new-gene-editing-method-cuts-hiv-dna-from-infected-cells-across-strains/
Category :
Tags:
Publish Date: 2026-02-19 10:36:00
